16087879|t|Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.
16087879|a|In investigating the role of metal ions in the pathogenesis of Huntington's disease, we examined the effects of clioquinol, a metal-binding compound currently in clinical trials for Alzheimer's disease treatment, on mutant huntingtin-expressing cells. We found that PC12 cells expressing polyglutamine-expanded huntingtin exon 1 accumulated less mutant protein and showed decreased cell death when treated with clioquinol. This effect was polyglutamine-length-specific and did not alter mRNA levels or protein degradation rates. Clioquinol treatment of transgenic Huntington's mice (R6/2) improved behavioral and pathologic phenotypes, including decreased huntingtin aggregate accumulation, decreased striatal atrophy, improved rotarod performance, reduction of weight loss, normalization of blood glucose and insulin levels, and extension of lifespan. Our results suggest that clioquinol is a candidate therapy for Huntington's disease and other polyglutamine-expansion diseases.
16087879	0	10	Clioquinol	Chemical	MESH:D007464
16087879	33	43	huntingtin	Gene	15194
16087879	93	113	Huntington's disease	Disease	MESH:D006816
16087879	114	119	mouse	Species	10090
16087879	156	161	metal	Chemical	MESH:D008670
16087879	190	210	Huntington's disease	Disease	MESH:D006816
16087879	239	249	clioquinol	Chemical	MESH:D007464
16087879	253	258	metal	Chemical	MESH:D008670
16087879	309	328	Alzheimer's disease	Disease	MESH:D000544
16087879	350	360	huntingtin	Gene	29424
16087879	393	397	PC12	CellLine	CVCL:0481
16087879	415	428	polyglutamine	Chemical	MESH:C097188
16087879	438	448	huntingtin	Gene	29424
16087879	538	548	clioquinol	Chemical	MESH:D007464
16087879	566	579	polyglutamine	Chemical	MESH:C097188
16087879	656	666	Clioquinol	Chemical	MESH:D007464
16087879	691	703	Huntington's	Disease	MESH:D006816
16087879	704	708	mice	Species	10090
16087879	710	714	R6/2	CellLine	CVCL:9233
16087879	783	793	huntingtin	Gene	15194
16087879	828	844	striatal atrophy	Disease	MESH:D001284
16087879	889	900	weight loss	Disease	MESH:D015431
16087879	925	932	glucose	Chemical	MESH:D005947
16087879	1005	1015	clioquinol	Chemical	MESH:D007464
16087879	1043	1063	Huntington's disease	Disease	MESH:D006816
16087879	1074	1106	polyglutamine-expansion diseases	Disease	MESH:D030342
16087879	Negative_Correlation	MESH:D007464	MESH:D030342
16087879	Negative_Correlation	MESH:D007464	MESH:D000544
16087879	Negative_Correlation	MESH:D007464	15194
16087879	Negative_Correlation	MESH:D007464	29424
16087879	Association	MESH:C097188	29424
16087879	Negative_Correlation	MESH:D007464	MESH:D015431
16087879	Negative_Correlation	MESH:D007464	MESH:D001284
16087879	Negative_Correlation	MESH:D007464	MESH:D006816
16087879	Negative_Correlation	MESH:D005947	MESH:D007464
16087879	Negative_Correlation	MESH:C097188	MESH:D007464

